Autoimmune diseases and pregnancy

Tinkani A., Nalli C., Khizroeva D. Kh., Bitsadze V. O., Lojacono A., Andreoli L., Shenfel`d I. Yu., Makatsariya A. D.

Best Practice & Research Clinical Endocrinology and Metabolism

Vol.33, Issue6, Num.101322

Опубликовано: 2019

Тип ресурса: Обзор

DOI:10.1016/j.beem.2019.101322

Аннотация:

Pregnancy in autoimmune diseases remains an argument of debate. In last years great improvements were done and with the correct medical support women with disease such as Systemic Lupus Erythematosus or Antiphospholipid Syndrome can afford a pregnancy and have healthy babies. The starting point is a good counselling. Women should be informed about risks that can occur taking some medications while pregnant and, on the other hand, that there are medications that can be safety assumed during pregnancy. Furthermore, there are known maternal risks factor such as the presence of antiphospholipid antibodies or anti-Ro/SSA antibodies that must be carefully manage by both rheumatologists and obstetrics. In addition, also disease activity during pregnancy can represent an issue. For all these reason, a multidisciplinary approach is mandatory in order to give our patients an optimal medical support, before, during and after pregnancy. © 2019

Ключевые слова:

autoimmune diseases; pregnancy; systematic review

phospholipid antibody; Ro antibody; antinuclear antibody; SS-A antibodies; autoimmune disease; counseling; human; pregnancy; Review; rheumatic disease; risk assessment; antiphospholipid syndrome; autoimmune disease; blood; complication; female; immunology; pregnancy; pregnancy complication; prenatal care; procedures; risk factor; systemic lupus erythematosus; Antibodies, Antinuclear; Antiphospholipid Syndrome; Autoimmune Diseases; Female; Humans; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications; Prenatal Care; Risk Factors

Язык текста: Английский

ISSN: 1532-1908

Tinkani A. Andzhela 1949-

Nalli C.

Khizroeva D. Kh. Dzhamilya Khizrievna 1973-

Bitsadze V. O. Viktoriya Omarovna 1970-

Lojacono A.

Andreoli L.

Shenfel`d I. Yu. Ieguda Yulius 1948-

Makatsariya A. D. Aleksandr Davidovich 1944-

Тинкани А. Анджела 1949-

Налли C.

Хизроева Д. Х. Джамиля Хизриевна 1973-

Бицадзе В. О. Виктория Омаровна 1970-

Лойаcоно А.

Андреоли Л.

Шенфельд И. Ю. Иегуда Юлиус 1948-

Макацария А. Д. Александр Давидович 1944-

Autoimmune diseases and pregnancy

Текст визуальный непосредственный

Best Practice & Research Clinical Endocrinology and Metabolism

W.B. Saunders

Vol.33, Issue6 Num.101322

2019

Обзор

autoimmune diseases pregnancy systematic review

phospholipid antibody Ro antibody antinuclear antibody SS-A antibodies autoimmune disease counseling human pregnancy Review rheumatic disease risk assessment antiphospholipid syndrome autoimmune disease blood complication female immunology pregnancy pregnancy complication prenatal care procedures risk factor systemic lupus erythematosus Antibodies, Antinuclear Antiphospholipid Syndrome Autoimmune Diseases Female Humans Lupus Erythematosus, Systemic Pregnancy Pregnancy Complications Prenatal Care Risk Factors

Pregnancy in autoimmune diseases remains an argument of debate. In last years great improvements were done and with the correct medical support women with disease such as Systemic Lupus Erythematosus or Antiphospholipid Syndrome can afford a pregnancy and have healthy babies. The starting point is a good counselling. Women should be informed about risks that can occur taking some medications while pregnant and, on the other hand, that there are medications that can be safety assumed during pregnancy. Furthermore, there are known maternal risks factor such as the presence of antiphospholipid antibodies or anti-Ro/SSA antibodies that must be carefully manage by both rheumatologists and obstetrics. In addition, also disease activity during pregnancy can represent an issue. For all these reason, a multidisciplinary approach is mandatory in order to give our patients an optimal medical support, before, during and after pregnancy. © 2019